LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.31623
 54.74 27.76 2766 5606 0.4934 0.8237
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 54.74 27.76 2834 5606 0.5055 0.8295
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 56.45 27.76 2076 5745 0.3613 0.7521
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 56.45 27.76 2096 5745 0.3648 0.7543
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 56.45 27.76 2465 5745 0.4290 0.7917
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 56.45 27.76 2520 5745 0.4386 0.7968
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 56.45 27.76 2900 5745 0.5048 0.8299
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 56.45 27.76 2956 5745 0.5145 0.8345
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 58.15 27.76 2149 5906 0.3638 0.7549
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 58.15 27.76 2183 5906 0.3696 0.7585
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 58.15 27.76 2591 5906 0.4387 0.7979
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 58.15 27.76 2634 5906 0.4459 0.8017
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 58.15 27.76 3066 5906 0.5191 0.8374
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 58.15 27.76 3112 5906 0.5269 0.8410
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 59.85 27.76 2252 6062 0.3715 0.7607
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 59.85 27.76 2285 6062 0.3769 0.7640
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 59.85 27.76 2724 6062 0.4493 0.8043
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 59.85 27.76 2776 6062 0.4579 0.8087
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 59.85 27.76 3132 6062 0.5166 0.8370
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 59.85 27.76 3231 6062 0.5329 0.8444
MN20160318_Q01
L08
MCF 10A-H2B-mCherry Dasatinib
0.31623
 61.56 27.76 2319 6217 0.3730 0.7627
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 61.56 27.76 2354 6217 0.3786 0.7661
MN20160318_Q01
G09
MCF 10A-H2B-mCherry Dasatinib
0.31623
 61.56 27.76 2762 6217 0.4443 0.8026
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 61.56 27.76 2872 6217 0.4619 0.8116
MN20160318_Q01
H12
MCF 10A-H2B-mCherry Dasatinib
0.31623
 61.56 27.76 3260 6217 0.5244 0.8413
MN20160318_Q01
L08